Skip to Main Content

Paper Details

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
J Clin Invest
6
2019
Cyclin-dependent kinase inhibitor, Cyclin-dependent kinase inhibitor 2B, atherosclerosis, efferocytosis

Datasets